Perinatal management of harlequin ichthyosis: a case report and literature review
- PMID: 20038941
- DOI: 10.1038/jp.2009.100
Perinatal management of harlequin ichthyosis: a case report and literature review
Abstract
Harlequin ichthyosis (HI) is a rare and severe form of congenital ichthyosis. Linked to deletion and truncation mutations of a keratinocyte lipid transporter, HI is characterized by diffuse epidermal hyperkeratinization and defective desquamation. At birth, the HI phenotype is striking with thick hyperkeratotic plate-like scales with deep dermal fissures, severe ectropion and eclabium, among other findings. Over the first months of life, the hyperkeratotic covering is shed, revealing a diffusely erythematous, scaly epidermis, which persists for the remainder of the patient's life. Although HI infants have historically succumbed in the perinatal period related to their profound epidermal compromise, the prognosis of HI infants has vastly improved over the past 20 years. Here, we report a case of HI treated with acitretin, focusing on the multi-faceted management of the disease in the inpatient setting. A review of the literature of the management of HI during the perinatal period is also presented.
Similar articles
-
Oral acitretin treatment in severe congenital ichthyosis of the neonate.Turk J Pediatr. 2002 Jan-Mar;44(1):61-4. Turk J Pediatr. 2002. PMID: 11858383
-
A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma.Br J Dermatol. 1996 Sep;135(3):448-53. Br J Dermatol. 1996. PMID: 8949442
-
Severe ectropion in lamellar ichthyosis managed medically with oral acitretin.Pediatr Dermatol. 2018 Mar;35(2):e117-e120. doi: 10.1111/pde.13410. Epub 2018 Jan 15. Pediatr Dermatol. 2018. PMID: 29334142
-
Successful treatment of harlequin ichthyosis with acitretin.Int J Dermatol. 2001 Jul;40(7):472-3. doi: 10.1046/j.1365-4362.2001.01173.x. Int J Dermatol. 2001. PMID: 11679007 Review. No abstract available.
-
Improved Management of Harlequin Ichthyosis With Advances in Neonatal Intensive Care.Pediatrics. 2017 Jan;139(1):e20161003. doi: 10.1542/peds.2016-1003. Epub 2016 Dec 20. Pediatrics. 2017. PMID: 27999114 Review.
Cited by
-
Retinoid Therapy in a Case of Harlequin Ichthyosis with a Short Literature Review.Case Rep Dermatol Med. 2024 Jan 12;2024:8729318. doi: 10.1155/2024/8729318. eCollection 2024. Case Rep Dermatol Med. 2024. PMID: 38250222 Free PMC article.
-
Case Report: Novel rare mutation c.6353C > G in the ABCA12 gene causing harlequin ichthyosis identified by whole exome sequencing.Front Pediatr. 2023 Feb 15;11:1128716. doi: 10.3389/fped.2023.1128716. eCollection 2023. Front Pediatr. 2023. PMID: 36873642 Free PMC article.
-
Ichthyosis Congenita, Harlequin Type: A Fatal Case Report.Cureus. 2018 Oct 30;10(10):e3524. doi: 10.7759/cureus.3524. Cureus. 2018. PMID: 30648059 Free PMC article.
-
A Unique Preparation and Delivery Method for Acitretin for Neonatal Harlequin Ichthyosis.J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):164-167. doi: 10.5863/1551-6776-23.2.164. J Pediatr Pharmacol Ther. 2018. PMID: 29720920 Free PMC article.
-
Ichthyosis with confetti: a rare diagnosis and treatment plan.BMJ Case Rep. 2014 Jul 10;2014:bcr2014204509. doi: 10.1136/bcr-2014-204509. BMJ Case Rep. 2014. PMID: 25012887 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous